![](/img/cover-not-exists.png)
Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%) in 19 subjects with mild to severe renal impairment: terminal half life and peak concentration (Cmax)remain unaffected
C Jungheinrich,R Scharpf,M Wargenau,F BepperlingVolume:
5
Language:
english
Journal:
Critical Care
DOI:
10.1186/cc1185
Date:
January, 2001
File:
PDF, 2.16 MB
english, 2001